TrialEuropean journal of pain (London, England)2026
Effects of Selective Sphingosine-1-Phosphate Receptor 1 Agonist, TRV045, on Evoked Pain Tests: An Exploratory, Four-Way Cross-Over Study in Healthy Volunteers.
Wouter A Bakker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.